Filing Details

 

---

Kala Pharmaceuticals Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

483119103

(CUSIP Number)

January 10, 2018

(Date of Event Which Requires Filing of this Statement)

 

 

 

*This percentage is calculated based upon 24,521,131 shares outstanding as of October 31, 2017, as set forth in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission on November 7, 2017.

 

 

*This percentage is calculated based upon 24,521,131 shares outstanding as of October 31, 2017, as set forth in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission on November 7, 2017.

 

 

*This percentage is calculated based upon 24,521,131 shares outstanding as of October 31, 2017, as set forth in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission on November 7, 2017.

 

 

 

 

 

 

 

Item 3.

Not Applicable

 

Item 4. Ownership:

GP VI is the sole general partner of OrbiMed Private Investments VI, LP (“OPI VI”), which holds 2,692,715 shares of Common Stock of the Issuer (“Shares”).  Advisors is an investment advisor in accordance with Rule 13d-1(b)(1)(ii)(E) under the Securities Exchange Act of 1934, as amended, and is the Managing Member of GP VI. Isaly is the Managing Member of Advisors and a control person in accordance with Rule 13d-1(b)(1)(ii)(G) under the Securities Exchange Act of 1934, as amended. On the basis of these relationships, GP VI, Advisors and Isaly may be deemed to share beneficial ownership of the Shares held by OPI VI.

(a)   Amount beneficially owned: See the response(s) to Item 9 on the attached cover page(s).

(b)   Percent of class: See the response(s) to Item 11 on the attached cover page(s).

(c)   Number of shares as to which such person has:

       (i)   Sole power to vote or to direct the vote: See the response(s) to Item 5 on the attached cover page(s).

       (ii)   Shared power to vote or to direct the vote: See the response(s) to Item 6 on the attached cover page(s).

       (iii)   Sole power to dispose or to direct the disposition of: See the response(s) to Item 7 on the attached cover page(s).

       (iv)   Shared power to dispose or to direct the disposition of: See the response(s) to Item 8 on the attached cover page(s).

Item 5. Ownership of Five Percent or Less of a Class.

Not Applicable.

Item 6. Ownership of More Than Five Percent on Behalf of Another Person.

 

See Item 4.

Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

 

Not Applicable.

Item 8. Identification and Classification of Members of the Group.

 

Not Applicable.

 

 

 

 

Item 9. Notice of Dissolution of Group.

 

Not Applicable.

Item 10. Certification.

By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

 

 

 

 

 

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: January 12, 2018

 

 

 

 

 

 

 

---